BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34320788)

  • 1. Timely diagnosis and treatment of acute promyelocytic leukemia should be available to all.
    Schuh AC
    Haematologica; 2022 Mar; 107(3):570-571. PubMed ID: 34320788
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia.
    Lo Coco F; Diverio D; Falini B; Biondi A; Nervi C; Pelicci PG
    Blood; 1999 Jul; 94(1):12-22. PubMed ID: 10381493
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute promyelocytic leukemia (APL) with an unusual cytogenetic presentation.
    Yorulmazoglu E; Gezer S; Gregory SA; Hsu WT
    Med Pediatr Oncol; 1998 Jan; 30(1):69-72. PubMed ID: 9371394
    [No Abstract]   [Full Text] [Related]  

  • 4. Arsenic trioxide may improve the prognosis of APL with ider(17)(q10): report of a rare adult case of acute promyelocytic leukemia with ider(17)(q10)t(15;17) showing poor response to all-trans retinoic acid.
    Tong H; Li K; Mei C; Wang H; Chen Z; Jin J
    Ann Hematol; 2011 Dec; 90(12):1493-4. PubMed ID: 21431323
    [No Abstract]   [Full Text] [Related]  

  • 5. Introducing biological features at diagnosis improves the relapse risk stratification in patients with acute promyelocytic leukemia treated with ATRA and chemotherapy.
    Breccia M; Stefania de Propris M; Molica M; Colafigli G; Minotti C; Diverio D; Latagliata R; Guarini A; Lo-Coco F; Foà R
    Am J Hematol; 2015 Sep; 90(9):E181-2. PubMed ID: 26119985
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute promyelocytic leukemia in children and adolescents.
    Stein EM; Tallman MS
    Acta Haematol; 2014; 132(3-4):307-12. PubMed ID: 25228556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia.
    Polampalli S; Choughule A; Prabhash K; Amare P; Baisane C; Kabre S; Mahadik S; Shinde S; Nair R; Banavali S
    Indian J Cancer; 2011; 48(1):60-7. PubMed ID: 21248444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated efficacy of all-trans-retinoic acid in an acute promyelocytic leukemia patient.
    Watanabe A; Inokuchi K; Mizuki T; Yamaguchi H; Yokose N; Dan K
    Am J Hematol; 2000 Sep; 65(1):87-8. PubMed ID: 10936873
    [No Abstract]   [Full Text] [Related]  

  • 9. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
    Rashidi A; Fisher SI
    Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interpretation of the Chinese guideline for diagnosis and treatment of childhood acute promyelocytic leukemia (2018)].
    ;
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):757-760. PubMed ID: 31594061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From the molecular model to the impact on prognosis: an overview on acute promyelocytic leukemia].
    Jácomo RH; Figueiredo-Pontes LL; Rego EM
    Rev Assoc Med Bras (1992); 2008; 54(1):82-9. PubMed ID: 18392492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid in acute promyelocytic leukemia.
    Sanz MA; Martín G; Díaz-Mediavilla J
    N Engl J Med; 1998 Feb; 338(6):393-4. PubMed ID: 9454087
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute promyelocytic leukemia: from treatment to genetics and back.
    Kogan SC; Bishop JM
    Oncogene; 1999 Sep; 18(38):5261-7. PubMed ID: 10498878
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Iaccarino L; Ottone T; Hasan SK; Divona M; Cicconi L; Lavorgna S; Alfonso V; Basso G; Barragán E; Bocchia M; Rego EM; Grimwade D; Voso MT; Lo-Coco F
    Leuk Lymphoma; 2018 May; 59(5):1268-1270. PubMed ID: 28838264
    [No Abstract]   [Full Text] [Related]  

  • 15. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
    Kitamura K; Takeshita A; Ono R; Naoe T
    Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current therapeutic concept of acute promyelocytic leukemia].
    Lengfelder E; Hehlmann R; Büchner T
    Dtsch Med Wochenschr; 2001 Sep; 126(39):1073-9. PubMed ID: 11602915
    [No Abstract]   [Full Text] [Related]  

  • 17. Guest editorial: acute promyelocytic leukemia: change from "highly fatal to highly curable" leukemia.
    Komatsu N
    Int J Hematol; 2014 Jul; 100(1):16-7. PubMed ID: 24912657
    [No Abstract]   [Full Text] [Related]  

  • 18. Misleading acute promyelocytic leukemia morphology.
    Wuillème S; Le Bris Y
    Blood; 2015 Jun; 125(24):3815. PubMed ID: 26266276
    [No Abstract]   [Full Text] [Related]  

  • 19. Tretinoin in the treatment of acute promyelocytic leukemia.
    Wong WM
    Cancer Pract; 1996; 4(4):220-3. PubMed ID: 8900766
    [No Abstract]   [Full Text] [Related]  

  • 20. Strategies for the treatment of acute promyelocytic leukemia.
    Frankfurt O; Tallman MS
    J Natl Compr Canc Netw; 2006 Jan; 4(1):37-50. PubMed ID: 16403403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.